AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,844,705 | +90.9% | 40,111 | +138.6% | 0.00% | – |
| Q2 2023 | $966,300 | -9.1% | 16,814 | -40.7% | 0.00% | – |
| Q1 2023 | $1,062,863 | +359.8% | 28,343 | +243.6% | 0.00% | – |
| Q4 2022 | $231,137 | -77.9% | 8,249 | -77.9% | 0.00% | – |
| Q3 2022 | $1,048,000 | +71.2% | 37,295 | +112.1% | 0.00% | – |
| Q2 2022 | $612,000 | +83.8% | 17,585 | +89.6% | 0.00% | – |
| Q1 2022 | $333,000 | -26.2% | 9,276 | -52.1% | 0.00% | – |
| Q4 2021 | $451,000 | – | 19,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 130,250 | $4,884,375 | 4.79% |
| SHAKER INVESTMENTS LLC/OH | 82,253 | $3,084,488 | 1.72% |
| Mesirow Institutional Investment Management, Inc. | 325,669 | $12,212,588 | 1.33% |
| Portolan Capital Management | 340,593 | $12,772,238 | 1.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 178,200 | $6,682,500 | 1.04% |
| Granite Investment Partners, LLC | 536,821 | $20,130,788 | 0.84% |
| Capital Impact Advisors, LLC | 15,304 | $573,900 | 0.70% |
| Hillsdale Investment Management Inc. | 155,038 | $5,813,926 | 0.50% |
| GLOBEFLEX CAPITAL L P | 89,192 | $3,344,700 | 0.41% |
| Jackson Creek Investment Advisors LLC | 25,877 | $970 | 0.41% |